4 YEAR REAL-WORLD OUTCOMES OF RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE RELATED MACULAR DEGENERATION

被引：0
|
作者：
Chew, Jamie [1 ]
Broadhead, Geoffrey [2 ]
Li, Haitao [1 ]
Chang, Andrew [1 ,2 ]
机构：
[1] Sydney Retina Clin & Day Surg, Sydney, NSW, Australia
[2] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2012年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kim, Leah N.
    Mehta, Hemal
    Barthelmes, Daniel
    Vuong Nguyen
    Gillies, Mark C.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (08): : 1418 - 1431
  • [2] Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration
    Citu, Maria Cristina
    Crosby-Nwaobi, Roxanne R.
    Eleftheriadou, Maria
    Vazquez-Alfageme, Clara
    Nicholson, Luke
    Sivaprasad, Sobha
    Hykin, Philip
    Hamilton, Robin D.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [3] Two Year Real World Outcomes of Ranibizumab Therapy for Neovascular Age Related Macular Degeneration (nAMD)
    Bhalla, Minak
    Muniraju, Ramu
    [J]. OPHTHALMOLOGICA, 2014, 232 : 4 - 4
  • [4] Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
    Chang, Yi-Sheng
    Lee, Wan-Ju
    Lim, Chen-Chee
    Wang, Shih-Hao
    Hsu, Sheng-Min
    Chen, Yi-Chian
    Cheng, Chia-Yi
    Teng, Yu-Ti
    Huang, Yi-Hsun
    Lai, Chun-Chieh
    Tseng, Sung-Huei
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [5] Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
    Yi-Sheng Chang
    Wan-Ju Lee
    Chen-Chee Lim
    Shih-Hao Wang
    Sheng-Min Hsu
    Yi-Chian Chen
    Chia-Yi Cheng
    Yu-Ti Teng
    Yi-Hsun Huang
    Chun-Chieh Lai
    Sung-Huei Tseng
    [J]. Scientific Reports, 8
  • [6] Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands
    Verbraak, Frank D.
    Ponsioen, Dirk L.
    Tigchelaar-Besling, Odette A. M.
    Nguyen, Vuong
    Gillies, Mark C.
    Barthelmes, Daniel
    Klaver, Caroline C. W.
    [J]. ACTA OPHTHALMOLOGICA, 2021, 99 (06) : E884 - E892
  • [7] Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration
    Brynskov, Troels
    Munch, Inger Christine
    Larsen, Tobias Malte
    Erngaard, Iiv
    Sorensen, Torben Lykke
    [J]. ACTA OPHTHALMOLOGICA, 2020, 98 (02) : 132 - 138
  • [8] Measuring real-world visual acuity outcomes for ranibizumab and aflibercept in treatment of neovascular age-related macular degeneration (nAMD)
    Karamat, Ayesha
    O'Neill, Charles
    Corradetti, Giulia
    Lindenberg, Sophiana
    Tojjar, Jasaman
    Almidani, Louay
    Do, Giang
    Mauger, Stephanie
    Nittala, Muneeswar
    Chauhan, Devinder
    Sadda, SriniVas
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    [J]. CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [10] Real-world UK NHS outcomes of a switch to Aflicercept from Ranibizumab in Neovascular age related macular degeneration (nvAMD)
    Citu, Maria Cristina
    Crosby-Nwaobi, Roxanne R.
    Hykin, Philip G.
    Hamilton, Robin
    Sivaprasad, Sobha
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
12345